Operating income increased 8.9%
Operating income changed +8.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +8.9% from the comparable as-filed period.
Inventory / revenue changed +13228 basis points from the comparable as-filed period.
R&D / revenue changed +3141 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -54890 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +100.0% from the comparable as-filed period.
Debt / assets changed -577 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed +97.7% from the comparable as-filed period.
Research & development changed -15.4% from the comparable as-filed period.
Working capital / assets changed +2048 basis points from the comparable as-filed period.
Debt / revenue changed +11764 basis points from the comparable as-filed period.
Inventory changed +17.3% from the comparable as-filed period.
Current liabilities changed -17.0% from the comparable as-filed period.
Receivables / revenue changed +3326 basis points from the comparable as-filed period.
Selling, general & administrative changed -14.2% from the comparable as-filed period.
Total assets changed +1.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.